such a one, S. Paul adviseth Titus, after the first, and second
Что думаешь? Оцени!
，详情可参考QuickQ
eprintln!("[mog] {}", msg.to_str().unwrap_or("?"));
Lowering costs would effectively expand access to early-stage clinical trials. Today, the high cost of manufacturing and running these trials means that only a small number of patients can participate. As an academic immuno-oncologist working in cell therapy at a prestigious U.S. academic institution —who asked to remain anonymous — told me, this often leads to heartbreaking choices. Because the size of academic grants only allows treatment for a handful of patients, he is forced to decide which patients receive the therapy and which do not.